QUALITY DETERMINATION INPROCESS FINISHED PRODUCT QUALITY TESTING PARAMETERS OF TRIAMCINOLONE ACETONIDE INJECTABLE SUSPENSION

http://dx.doi.org/10.31703/gdddr.2018(III-I).04      10.31703/gdddr.2018(III-I).04      Published : Dec 2018
Authored by : Rana Muhammad Awais Khan , Mubashar Rehman

04 Pages : 23-30

    Abstract

    Triamcinolone acetonide is an antiinflammatory drug that has been used for more than 50 years for the treatment of various inflammatory disorders including the arthritis & gout etc. Moreover, in recent years its use has been rapidly increased for the treatment of retinal vasculature disease and Uveitis, periocular and intraocular treatment. This review summarizes the whole manufacturing process of this formulation along with the complete in-process QC & Finished dosage form test parameters that ensures the efficacy and safety of this drug. Furthermore, the industrial requirements in the production and QC department to manufacture this product are emphasized to optimize the production as well as the quality of the Product.

    Key Words

    Quality Control, Parenteral, In-Process, Triamcinolone Acetonide

    Introduction

    Triamcinolone Acetonide is used therapeutically as an anti-inflammatory drug that reduces the allergic reactions, swelling and various inflammatory disorders for example, arthritis, gout, Skin diseases and numerous other medical problems including retinal vasculature disease and Uveitis (Jermak, Dellacroce, Heffez, & Peyman, 2007; Yilmaz et al., 2009). It is available in parenteral form for those who cannot take it orally. It is basically Corticosteroid that acts on the steroid receptors present on the intracellular receptors. 

    Immediate supervision of the physician is compulsory during administration or should only be done by the Doctor. This drug is available in market in the two dosage forms: 

    1-Extended-release powder for suspension 

    2-Suspension


    Description

    Brand name: Tramacort A

    Generic name: Triamcinolone Acetonide Injectable Suspension USP

    Composition: 40mg/ml

    Manufactured by Trigon Pharmaceuticals (pvt) Ltd.

     


    Industrial Layout Requirement

    Figure 1

    Complete layout of the Industry to manufacture the Triamcinolone Acetonide in parenteral Dosage form

    Personal Flow

     

    A unidirectional flow is maintained within the production area to avoid any crowded and discontinuous pattern.

    Sterile Corridors are used, and positive air pressures are maintained. Air locks are used for entry and exit from the production area to avoid the entry of air from outside into the manufacturing area 

    Figure 2

    Flow of the raw materials and intermediates during the Manufacturing of Triamcinolone Acetonide Injectables

    Material Flow


    Raw Materials Requirement Per Ampoule

    Ø  Triamcinolone Acetonide                             40mg

    Ø  Sodium Chloride                                                6.5mg

    Ø  Benzyl Alcohol                                                    9.9mg

    Ø  Carboxymethylcellulose         7.5mg

    Ø  Polysorbate 80                                            0.4mg

    Ø  Sodium hydroxide / HC QS to adjust pH between 5 to 7.5


     

     

    Area Requirements for parenteral Manufacturing

    Table 1. Requirements of the Area for the Parenteral Manufacturing

    Functions

    Area

    Square Meter

    Percentage

    Production

    11094

    45.1

    Warehouse

    7606

    30.9

    Utility

    1716

    4.1

    Quality Control

    1716

    7.0

    Administration

    1018

    4.1

    Maintenance

    1014

    4.5

    Employee Services

    1014

    4.1

    Security

    39

    0.9

    Total

    24607

    100

     

    Quality Testing of Raw Materials


    Quality Assurance inspector checks the raw material section after specific intervals and raw materials are tested before purchasing form the supplier. These tests are performed for every excipient as mentioned in USP.


     

    Table 2. Quality Control Tests for the Raw Materials

    Identification

    Limit Tests

    Identification

    Purity

    Physical properties

    Purity

    Particle size

    Organic volatile Impurities

    Particle size

     

    Raw Materials Storage


    Each raw material is stored in a separate container having a label attached on it, indicating

    Ø  Material name & Internal Code

    Ø  Date

    Ø  QC and QA clearance

    Ø  Batch no. given by supplier

    Ø  Expiry date or date beyond retesting is necessary.

    Temperature and humidity are controlled within 23-27 degree and 45-55% respectively.

     

    Dispensing

    Dispensing of raw materials is done in a separate area within the raw material store. Raw material store supredent, Quality Assurance Inspector, Production pharmacist and Technician for weighing purpose must be present at the time of dispensing. Each raw material is weighed according to batch requirement and dispensed in a separate container / package. Dispensing conditions are mostly the same as the raw material store.

     

    Line Clearance 1

    Quality Assurance Inspector gives the line clearance

    and dispensed materials are carried form the raw material store to the Sterile Production Area.

     

    Line Clearance 2

    Quality assurance inspector check the conditions of the mixing as required and then gives the clearance for the mixing operation.

     

    Mixing & Blending

    Mixing is done at 25degree temperature and 35-40 % humidity is maintained during the mixing process. Specific equipment is used depending upon the batch size.

     

    In-Process Quality Control of Mixed Ingredients

    After the mixing, sample is sent to the QC lab to check the homogeneity of the mixing and other different tests needed to be performed to check the quality of the sample according to the USP mentioned procedures.

    Ø  Content Uniformity / Blend Uniformity

    Ø  Particle size                         

     

    Preparation of Water for Injection

    Water required as a solvent (aqeous phase) is treated

    by several methods that provide the characteristics mentioned in the table. These characteristics must be fulfilled in order to use this water as an excipient for pharmaceutical purpose.

     


    Table 3. Water for Injection Requirements

    S.No

    Parameters

    Specifications

    1

    Appearance

    Clear, colorless, no visible particles

    2

    Odor

    Odorless

    3

    pH

    5.0-7.0

    4

    Acidity or alkalinity

    NMT0.1 ml of 0.01M NaOH/Hcl

    5

    Chloride

    0 ppm

    6

    Oxidizable Substances

    0 ppm

    7

    Sulphate

    0 ppm

     

    Dechlorination


    Removal of chlorine done by high dosage of UV or filtration through activated Carbon Media.

     

    Ion Removal

    Removal of ions done by membrane process (reverse osmosis & Nano filtration membranes), exchange process or distillation process. Ions, particulate matter, organic compounds and even living organisms are removed in this process.

     

    Bacterial Control

    Bacterial control is usually applied during the during the processing, storage and even distribution. Equipments used are UV lights, ozone generation systems and heating systems for the non-thermal, Chemical and Thermal removal of bacteria respectively.

     

    Removal of Specific Impurities

    Depending upon the source of Water different types of impurities can be present in water that must be removed by proper process e.g., iron, manganese, hydrogen sulphide, hardness ions, particulate matter, and high conductivity.

     

    Storage

    Stored in special tanks containing ultraviolet lamps. It can be stored for a period up to a month. Care and hygiene are maintained during the storage and bacterial control is still incorporated in this stage.

     

    Quality Control Tests for Water for Injection

    ·          Sterility Test

    ·          Bacterial Endotoxin Test

    ·          Pyrogen Test

     

    Addition of Solvent in the Rest of Mixed Raw Materials

    This is done under Aseptic Conditions at the temperature of 25 degrees and humidity maintained at 35 percent.

    Specific equipment for liquid solid mixing is used depending upon the batch size

    Figure 3

    Flow of Sterilized Raw Materials till the Final Suspension

    In-process Quality Control Test for Parenteral Suspensions before Filling

    Appearance

    A graduated transparent glass cylinder is used to check the appearance. The sediment’s Colour and uniformity is checked during this investigation. Presence of air pockets or air breaks is noted. Any material coagulated and sticking to the container wall is checked too.


    Density

    One of main parameters in the in-process quality control of this formulation is Density and Specific Gravity. Entrapped air in the suspension formulation shows itself in the form of decrease in the density. For the measurements of densities, the suspension formulation must be uniform throughout the container. Hydrometers are used to measure the density.


    Viscosity

    Viscosity is measured using an Ostwald viscometer. TACA injectable suspension has a viscosity range of 2-12cps.


    Particle Size

    Particle size is checked by optical microscopic method. TACA of 4% (w/v) has a mean volume diameter of 3-10?m.


    pH Value

    pH measured using a pH meter. Triamcinolone acetonide injectable suspension should have a pH value between 5 and 7.5.


    Pourability

    Suspension is checked for the pourability in phases to ensure the proper pourability of the formulation to avoid any problems or defects during the filling procedure or during the handling by the patient.


    Zeta Potential

    Zeta Potential is measured using a zeta sizer and acceptable range of zeta potential is -20 to +20 mv. 


    Treatment of Ampoules

    Ampoules made of type 1 glass provided by the supplier are used for the filling purposes and they require specific treatment before filling preparation.

    ? Colour: Colourless transparent ampoules

    ? Dimensions: 10.75 x 70 x 0.50mm 


    Line Clearance 3

    Quality Assurance inspector also inspects the process of Ampoules treatment and specific conditions e.g. the speed of the washing machine and even the number of persons required in a particular area are checked by QAI and ultimately if all the requirements are fulfilled then Process is continued.


    Washing

    Automatic ampoule washer is used for cleaning the containers. Ampoules are washed at a speed of 250 ampoules per minute by an automatic machine. There are some specific gripping techniques used in this machine that hold the ampoules and then invert them in order for the cleaning process. Pressurized as well as positive pressure nozzles are used to do the washing of the ampoules. Cleaned ampoules are then collected in a tray after they are washed through a feeding path in a straight position.

    There are 6 washing stations in the machine and 3 needles for the air removal and 3 needles for the water removal are present in each station. Cleaning agents are hold and pumped by three pumps with three 25 litre tanks are also present in the machine. Gripper cassettes are also present in each station that holds the ampoules and turn them in the neck down position.  Feeding and exiting the machine is done totally automatically

    Stainless steel 316 is used to manufacture all the internal surfaces that helps in preventing the corrosion. FDA approved materials are required to make the other parts that are not made with the Stainless steel 316. CGMP standards are used to make the fabrication and materials and their quality is guaranteed by them.(Lee, Shin, Kim, Eun, & Surgery, 2013)


    Sterilization of Ampoules

    Sterilization of ampoules is done for 13 minutes at 115 degrees.

    After that they are cooled at -30 to -40 degrees for some time and then exposed to the conditions for primary freeze drying for about 6 hours. 


    Storage

    Ampoules then are stored under aseptic conditions in airtight area and controlled temperature and humidity.

    Filling & Sealing of Ampoules

    Line Clearance 4

    Here the aseptic conditions are checked and then allowed to start the filling process and a small sample is tested after filling for the required volume , weight variation, particle contamination and leaker test and oxygen content test are also performed to judge the accuracy of the filling and sealing procedure, If everything is under-controlled then the line clearance is given for the batch filling and sealing operation.


    Performance Qualification of Filling Machine

    Weight Variation test: 10 containers must be within 85-115% of target content or NMT 1 out of 30 containers outside of the 85-115% and no unit must be outside the 75-125%.

    Filling Volume Accuracy: It should be within plus minus 1 % of adjusted volume.

    Particle Contamination

    This test is performed according to the USP test for particulate matter.

    Leaker Test

    Leak is detected by submerging the ampoule in deeply coloured dye solution (0.5-1% methylene blue). Capillaries of less than 15 um cannot be detected by this method.


    Oxygen Content

    If the filler produces a nitrogen purge, the head space gas should be analyzed for oxygen content.


    Operation

    Ampoules are filled using an automatically filling and sealing machine. Ampoules that are already sterilized are loaded on a tray and then tray is loaded into the slant hopper unit directly. Ampules are delivered to the eccentric ampoule rack that continuously moves in single or two or four or six, one by one.(Kupiec, 2004)


    Quality Control Tests of the Filled Ampoules

    Following Tests are performed on the filled ampoules according to USP Specifications (Akers, Larrimore, & Guazzo, 2002; Deshmukh, Salunkhe, Deshmukh, & Shete, 2015)

    ? Deliverable Volume

    ? Leaker test

    ? Clarity Test

    ? Pyrogen Test

    ? Sterility Test

    ? Content Uniformity Test


    Labelling of Ampoules

    Ampoule labelling machine is that prints the label horizontally on the ampoules. This specific label contains all the required information according to the guidelines for labeling of parenterals (Deshmukh et al., 2015).


    Packaging of the Ampoules

    Within the raw material store packaging store section is separate area where the primary, secondary, and tertiary materials for packing are stored. They are dispensed when given the line clearance by the Quality Assurance inspector and carried to the packaging section where each ampoule is packaged in single unit container and entire batch is packages in tertiary containers (Akers et al., 2002).


    Finished Product Tests

    Appearance of Phases, Colour & Crystal Determination

    A graduated transparent glass cylinder is used to check the appearance. The sediment’s Colour and uniformity is checked during this investigation. Presence of air pockets or any breaks is noted. Any material coagulated and sticking to the container wall is checked too.


    Sedimentation Volume

    TACA Injectable suspension must have a degree of flocculation greater than 5.


    Measurement of Zeta Potential

    Zeta Potential Measurement is done in the same way as described above in the IPQC.


    Re-Dispersibility

    Upon settling the particles of the formulation, they should be easily redispersible.


    Rheological Measurement

    Preparation must have good flow properties for the good syringablity and pourability properties.


    pH Value

    Triamcinolone acetonide injectable suspension should have a pH value between 5 and 7.5.


    Universal Tests for Triamcinolone Acetonide Injectable Suspension (USP)

    Description

    Triamcinolone Acetonide occurs as White to cream colored particles suspended in the aqueous phase.


    Identification of Triamcinolone Acetonide Suspension

    As per USP identification test is performed to confirm the presence of active ingredient.


    Assay

    Assay is performed as per USP Monograph specifications.

    Triamcinolone acetonide injectable suspension contains not less than 90.0 percent and not more than 115.0 percent of the labeled amount of C24H31FO6.


    Sterility Test

    Sterility test is performed according to USP by the membrane filtration method and no growth of microorganisms should be observed in the product (Akers et al., 2002).


    Bacterial Endotoxin Test

    TACA Injectable suspension contains not more than 4.4 USP Endotoxin Units per mg of triamcinolone acetonide by testing according to the requirements for the bacterial endotoxin test (Williams, 2007).


    Foreign & Particulate matter Test

    The limits for the foreign and particulate matter test for this formulation are the following: all the tested units must not contain more than 6000 average number of particles equal to or greater than 10 micrometer and should not be more than 600 particles per container equal to greater than 25 micrometer (Akers et al., 2002).


    Container Contents

    Upon individual examination of the containers the volume of each container should not be less than nominal value or in case of  the containers having a nominal volume of 2 ml or less, should not be less than the sum of the nominal volumes of the containers taken together (Deshmukh et al., 2015).


    Labeling

    FDA is responsible for ensuring the compliance with

    the current regulation to label a product. The date beyond use or expiry date must be present on both the container and package label. Package label must also contain the storage conditions that are recommended if the container is packaged. All other requirements as well as storage conditions must be indicated on the container label if the container is not packaged individually. National and international requirements must be fulfilled during the labelling of the Formulation (Deshmukh et al., 2015).

    Specific Test for Parenteral Suspensions (USP)

    Uniformity of Dosage Unit

    Content Uniformity test is applied on the 10 containers first. If the criteria is not met then 20 more containers are selected and overall content uniformity is checked in 30 containers.

    Acceptance value is calculated by the:  Av= ?M-x?+ Ks where x-bar is mean of assay values and K is constant and s is standard deviation while M is the reference value.


    Criteria

    The acceptance value should be less than or equal to 15. All the assay values must be in the range in between the upper and lower limits.


    Antimicrobial Preservatives

    Antimicrobial preservative should not be more than 20 % of the labelled amount.


    Storage in Warehouse

    Finished products then are placed in the warehouse from where they will be shipped to the distributors.

    Conditions for the storage in the warehouse are the 

    Temperature: 23-27 degrees

    Humidity: 35-45 %

    Conclusion

    Various in- process quality Control parameters are there to be controlled during the manufacturing of the Triamcinolone Acetonide that effect the quality of the final suspension formed. Quality assurance is the main factor involved that must be able to optimize the production by controlling the process and ensures the best quality of each process and the intermediate after each step. Industrial requirements including the area, personal flow as well as material flow must be fulfilled in order to maximize the output by using the quality raw materials that must be tested for their properties after receiving from the supplier 

References

  • Akers, M. K., Larrimore, M. K., & Guazzo, D. (2002). Parenteral quality control: sterility, pyrogen, particulate, and package integrity testing: CRC Press.
  • Akers, M. K., Larrimore, M. K., & Guazzo, D. (2002). Parenteral quality control: sterility, pyrogen, particulate, and package integrity testing: CRC Press.
  • Jermak, C. M., Dellacroce, J. T., Heffez, J., & Peyman, G. A. (2007). Triamcinolone Acetonide in Ocular Therapeutics. Survey of Ophthalmology, 52(5), 503-522. doi:
  • Kupiec, T. J. I. j. o. p. c. (2004). Quality-control analytical methods: High-performance liquid chromatography. 8, 223-227.
  • Lee, Y. C., Shin, S. Y., Kim, S. W., Eun, Y. G. J. O. H., & Surgery, N. (2013). Intralesional injection versus mouth rinse of triamcinolone acetonide in oral lichen planus: a randomized controlled study. 148(3), 443-449.
  • Williams, K. L. (2007). Endotoxins: pyrogens, LAL testing and depyrogenation: CRC Press.
  • Yilmaz, T., Weaver, C. D., Gallagher, M. J., Cordero- Coma, M., Cervantes-Castaneda, R. A., Klisovic, D., & Larson, R. J. J. O. (2009). Intravitreal triamcinolone acetonide injection for treatment of refractory diabetic macular edema: a systematic review. 116(5), 902-913.

Cite this article

    APA : Khan, R. M. A., & Rehman, M. (2018). Quality Determination (In-process & Finished product Quality Testing Parameters) of Triamcinolone Acetonide Injectable Suspension. Global Drug Design & Development Review, III(I), 23-30. https://doi.org/10.31703/gdddr.2018(III-I).04
    CHICAGO : Khan, Rana Muhammad Awais, and Mubashar Rehman. 2018. "Quality Determination (In-process & Finished product Quality Testing Parameters) of Triamcinolone Acetonide Injectable Suspension." Global Drug Design & Development Review, III (I): 23-30 doi: 10.31703/gdddr.2018(III-I).04
    HARVARD : KHAN, R. M. A. & REHMAN, M. 2018. Quality Determination (In-process & Finished product Quality Testing Parameters) of Triamcinolone Acetonide Injectable Suspension. Global Drug Design & Development Review, III, 23-30.
    MHRA : Khan, Rana Muhammad Awais, and Mubashar Rehman. 2018. "Quality Determination (In-process & Finished product Quality Testing Parameters) of Triamcinolone Acetonide Injectable Suspension." Global Drug Design & Development Review, III: 23-30
    MLA : Khan, Rana Muhammad Awais, and Mubashar Rehman. "Quality Determination (In-process & Finished product Quality Testing Parameters) of Triamcinolone Acetonide Injectable Suspension." Global Drug Design & Development Review, III.I (2018): 23-30 Print.
    OXFORD : Khan, Rana Muhammad Awais and Rehman, Mubashar (2018), "Quality Determination (In-process & Finished product Quality Testing Parameters) of Triamcinolone Acetonide Injectable Suspension", Global Drug Design & Development Review, III (I), 23-30
    TURABIAN : Khan, Rana Muhammad Awais, and Mubashar Rehman. "Quality Determination (In-process & Finished product Quality Testing Parameters) of Triamcinolone Acetonide Injectable Suspension." Global Drug Design & Development Review III, no. I (2018): 23-30. https://doi.org/10.31703/gdddr.2018(III-I).04